SAT 2002 komponent 3

Primær information

  • Handelsnavn:
  • SAT 2002 komponent 3 Pulver bejdse
  • Lægemiddelform:
  • Pulver bejdse
  • Sammensætning:
  • 980 g/kg thiram
  • Brugt til:
  • Planter
  • Medicin typen:
  • agrokemiske

Dokumenter

  • for den brede offentlighed:
  • Oplysningerne indlægssedlen for dette produkt er i øjeblikket ikke tilgængelig, kan du sende en anmodning til vores kundeservice, og vi vil give dig besked, så snart vi er i stand til at opnå det.


    Anmode informationsbrochure for offentligheden.

  • for sundhedspersonale:
  • Oplysningerne indlægssedlen for dette produkt er i øjeblikket ikke tilgængelig, kan du sende en anmodning til vores kundeservice, og vi vil give dig besked, så snart vi er i stand til at opnå det.


    Anmode informationsbrochure for sundhedspersonale.

Lokation

  • Fås i:
  • SAT 2002 komponent 3 Pulver bejdse
    Danmark
  • Sprog:
  • dansk

Andre oplysninger

Status

  • Kilde:
  • SEGES Landbrug & Fødevarer
  • Autorisation status:
  • Udgået
  • Sidste ændring:
  • 08-02-2018
  • Oplysningerne indlægssedlen for dette produkt er i øjeblikket ikke tilgængelig, kan du sende en anmodning til vores kundeservice, og vi vil give dig besked, så snart vi er i stand til at opnå det.

    Anmode informationsbrochure for offentligheden.

Der er ingen sikkerhedsadvarsler relateret til dette produkt.

26-3-2018

Rate of Antibiotic-Resistant Infections Doubled Since 2002, Cost Tops $2B Annually

Rate of Antibiotic-Resistant Infections Doubled Since 2002, Cost Tops $2B Annually

Rates of antibiotic-resistant infections have roughly doubled since 2002, and the cost of care now tops $2 billion per year in the United States, researchers report in an article published online March 22 in Health Affairs.

US - RxList

26-3-2018

Antibiotic-Resistant Infections Doubled Since 2002

Antibiotic-Resistant Infections Doubled Since 2002

Rate of Antibiotic-Resistant Infections Doubled Since 2002, Cost Tops $2B Annually

US - eMedicineHealth

23-3-2018

EU/3/18/2002 (Pharmadev Healthcare Ltd)

EU/3/18/2002 (Pharmadev Healthcare Ltd)

EU/3/18/2002 (Active substance: Ribavirin) - Orphan designation - Commission Decision (2018)1890 of Fri, 23 Mar 2018 European Medicines Agency (EMA) procedure number: EMA/OD/224/17

Europe -DG Health and Food Safety

19-3-2018

Indigestion (Dyspepsia, Upset Stomach Pain) Symptoms, Relief Remedies, Medicine

Indigestion (Dyspepsia, Upset Stomach Pain) Symptoms, Relief Remedies, Medicine

Title: Indigestion (Dyspepsia, Upset Stomach Pain) Symptoms, Relief Remedies, MedicineCategory: Diseases and ConditionsCreated: 4/10/2002 12:00:00 AMLast Editorial Review: 3/19/2018 12:00:00 AM

US - MedicineNet

19-3-2018

Date Rape Drugs

Date Rape Drugs

Title: Date Rape DrugsCategory: Diseases and ConditionsCreated: 11/18/2002 12:00:00 AMLast Editorial Review: 3/19/2018 12:00:00 AM

US - MedicineNet

20-1-2018

EU/3/17/1965 (Duchenne UK)

EU/3/17/1965 (Duchenne UK)

EU/3/17/1965 (Active substance: Metformin and L-citrulline) - Orphan designation - Commission Decision (2018)387 of Sat, 20 Jan 2018 European Medicines Agency (EMA) procedure number: EMA/OD/154/17

Europe -DG Health and Food Safety

15-12-2017

Rheumatoid Factor (RF)

Rheumatoid Factor (RF)

Title: Rheumatoid Factor (RF)Category: Procedures and TestsCreated: 1/28/2002 12:00:00 AMLast Editorial Review: 12/15/2017 12:00:00 AM

US - MedicineNet

15-12-2017

Osteoarthritis of the Hands

Osteoarthritis of the Hands

Title: Osteoarthritis of the HandsCategory: Doctor's & Expert's views on SymptomsCreated: 4/1/2002 12:00:00 AMLast Editorial Review: 12/15/2017 12:00:00 AM

US - MedicineNet

14-12-2017

DeQuervain's Tenosynovitis

DeQuervain's Tenosynovitis

Title: DeQuervain's TenosynovitisCategory: Diseases and ConditionsCreated: 2/3/2002 12:00:00 AMLast Editorial Review: 12/14/2017 12:00:00 AM

US - MedicineNet

16-8-2017

Headache

Headache

Title: HeadacheCategory: Diseases and ConditionsCreated: 5/31/2002 12:00:00 AMLast Editorial Review: 8/16/2017 12:00:00 AM

US - MedicineNet

23-5-2017

Homocysteine (Normal and Elevated Levels Blood Test)

Homocysteine (Normal and Elevated Levels Blood Test)

Title: Homocysteine (Normal and Elevated Levels Blood Test)Category: Procedures and TestsCreated: 3/15/2002 12:00:00 AMLast Editorial Review: 5/23/2017 12:00:00 AM

US - MedicineNet

22-4-2017

EU/3/17/1861 (Biological Consulting Europe Ltd)

EU/3/17/1861 (Biological Consulting Europe Ltd)

EU/3/17/1861 (Active substance: (S)-8-{2-amino-6-[1-(5-chloro-biphenyl-2-yl)-(R)-2,2,2-trifluoro-ethoxy]-pyrimidin-4-yl}-2,8-diaza-spiro[4.5]decane-3-carboxylic acid ethyl ester) - Orphan designation - Commission Decision (2017)2780 of Sat, 22 Apr 2017 European Medicines Agency (EMA) procedure number: EMA/OD/299/16

Europe -DG Health and Food Safety

22-4-2017

EU/3/17/1864 (NBMI Science Limited)

EU/3/17/1864 (NBMI Science Limited)

EU/3/17/1864 (Active substance: Emeramide) - Orphan designation - Commission Decision (2017)2783 of Sat, 22 Apr 2017 European Medicines Agency (EMA) procedure number: EMA/OD/329/16

Europe -DG Health and Food Safety

22-4-2017

EU/3/17/1863 (bluebird bio France)

EU/3/17/1863 (bluebird bio France)

EU/3/17/1863 (Active substance: Autologous T lymphocyte-enriched population of cells transduced with a lentiviral vector encoding a chimeric antigen receptor targeting human B cell maturation antigen with 4-1BB and CD3-zeta intracellular signalling domains) - Orphan designation - Commission Decision (2017)2782 of Sat, 22 Apr 2017 European Medicines Agency (EMA) procedure number: EMA/OD/270/16

Europe -DG Health and Food Safety